News
2d
MedPage Today on MSNTruly Novel RA Drug Passes Mid-Stage TestPatients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...
A study by scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) introduces a more cost-effective, scalable ...
A team of researchers from the University of Wollongong (UOW) have discovered that a unique trio of medications could hold ...
The chip that is inserted into the 10X Genomics software, allowing researchers to analyze DNA and RNA simultaneously.
Researchers at Bristol University have created a lay summary for their research. The project will investigate the mechanisms of a new clinical drug combination currently in clinical trials for breast ...
Combining statins with another drug, ezetimibe, significantly reduces ... a deadly delight compared to plant oils, study says This combination therapy would prevent more than 330,000 deaths ...
A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the Department of Surgery at the University of Utah (the U), is testing a new ...
On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...
One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...
Most patients who enroll in the Lung-MAP precision medicine trial in non-small cell lung cancer can now be matched to a targeted investigational treatment based on the results of their prior genomic ...
4d
News-Medical.Net on MSNResearchers develop drug cocktail to target enterovirusesEnteroviruses are a group of viruses that cause everything from the common cold to meningitis, polio, type 1 diabetes, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results